APO Research
Talk to an analyst

APO RESEARCH · REPORT

Seasickness Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Seasickness Medicine Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchSeasickness Medicine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Seasickness Medicine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Seasickness Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Seasickness Medicine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Seasickness Medicine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Seasickness Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Seasickness Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Seasickness Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Seasickness Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Seasickness Medicine include Baxter International, Caleb Pharmaceuticals, Myungmoon Pharm, Prestige Brands, WellSpring Pharmaceutical Corporation, GlaxoSmithKline, Pfizer, Mylan and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Seasickness Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Seasickness Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Seasickness Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Seasickness Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Seasickness Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Seasickness Medicine Market by Company

Baxter International

Caleb Pharmaceuticals

Myungmoon Pharm

Prestige Brands

WellSpring Pharmaceutical Corporation

GlaxoSmithKline

Pfizer

Mylan

Novartis

Seasickness Medicine Segment by Type

Anticholinergic

Antihistamines

Others

Seasickness Medicine Segment by Application

Adults

Children

Seasickness Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasickness Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Seasickness Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasickness Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Seasickness Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Seasickness Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anticholinergic Table 2. Major Company of Antihistamines Table 3. Major Company of Others Table 4. Global Seasickness Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 6. Global Seasickness Medicine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Seasickness Medicine Sales Market Share in Value by Type (2021-2026) Table 9. Global Seasickness Medicine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Seasickness Medicine Sales by Type (2027-2032) & (K Units) Table 11. Global Seasickness Medicine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Seasickness Medicine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Seasickness Medicine Sales Market Share in Value by Type (2027-2032) Table 14. Global Seasickness Medicine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 16. North America Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 18. Europe Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Seasickness Medicine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Seasickness Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Seasickness Medicine Industry Trends Table 26. Seasickness Medicine Industry Drivers Table 27. Seasickness Medicine Industry Opportunities and Challenges Table 28. Seasickness Medicine Industry Restraints Table 29. Global Seasickness Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Seasickness Medicine Revenue Market Share by Company (2021-2026) Table 31. Global Seasickness Medicine Sales by Company (2021-2026) & (K Units) Table 32. Global Seasickness Medicine Sales Share by Company (2021-2026) Table 33. Global Seasickness Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Seasickness Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Seasickness Medicine Major Company Production Sites and Headquarters Table 36. Global Seasickness Medicine Company, Product Type & Application Table 37. Global Seasickness Medicine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Seasickness Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Seasickness Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Seasickness Medicine Sales by Region (2021-2026) & (K Units) Table 42. Global Seasickness Medicine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Seasickness Medicine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Seasickness Medicine Sales Market Share in Value by Region (2021-2026) Table 45. Global Seasickness Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Seasickness Medicine Sales by Region (2027-2032) & (K Units) Table 47. Global Seasickness Medicine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Seasickness Medicine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Seasickness Medicine Sales Market Share in Value by Region (2027-2032) Table 50. Global Seasickness Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Seasickness Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 53. Global Seasickness Medicine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Seasickness Medicine Sales Market Share in Value by Application (2021-2026) Table 56. Global Seasickness Medicine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Seasickness Medicine Sales by Application (2027-2032) & (K Units) Table 58. Global Seasickness Medicine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Seasickness Medicine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Seasickness Medicine Sales Market Share in Value by Application (2027-2032) Table 61. Global Seasickness Medicine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 63. North America Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 65. Europe Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Seasickness Medicine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Seasickness Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter International Company Information Table 73. Baxter International Business Overview Table 74. Baxter International Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Baxter International Seasickness Medicine Product Portfolio Table 76. Baxter International Recent Development Table 77. Caleb Pharmaceuticals Company Information Table 78. Caleb Pharmaceuticals Business Overview Table 79. Caleb Pharmaceuticals Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Caleb Pharmaceuticals Seasickness Medicine Product Portfolio Table 81. Caleb Pharmaceuticals Recent Development Table 82. Myungmoon Pharm Company Information Table 83. Myungmoon Pharm Business Overview Table 84. Myungmoon Pharm Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Myungmoon Pharm Seasickness Medicine Product Portfolio Table 86. Myungmoon Pharm Recent Development Table 87. Prestige Brands Company Information Table 88. Prestige Brands Business Overview Table 89. Prestige Brands Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Prestige Brands Seasickness Medicine Product Portfolio Table 91. Prestige Brands Recent Development Table 92. WellSpring Pharmaceutical Corporation Company Information Table 93. WellSpring Pharmaceutical Corporation Business Overview Table 94. WellSpring Pharmaceutical Corporation Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. WellSpring Pharmaceutical Corporation Seasickness Medicine Product Portfolio Table 96. WellSpring Pharmaceutical Corporation Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Seasickness Medicine Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Seasickness Medicine Product Portfolio Table 106. Pfizer Recent Development Table 107. Mylan Company Information Table 108. Mylan Business Overview Table 109. Mylan Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mylan Seasickness Medicine Product Portfolio Table 111. Mylan Recent Development Table 112. Novartis Company Information Table 113. Novartis Business Overview Table 114. Novartis Seasickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Novartis Seasickness Medicine Product Portfolio Table 116. Novartis Recent Development Table 117. North America Seasickness Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Seasickness Medicine Sales by Country (2021-2026) & (K Units) Table 119. North America Seasickness Medicine Sales Market Share by Country (2021-2026) Table 120. North America Seasickness Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Seasickness Medicine Sales Market Share Forecast by Country (2027-2032) Table 122. North America Seasickness Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Seasickness Medicine Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Seasickness Medicine Market Share by Country (2021-2026) Table 125. North America Seasickness Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Seasickness Medicine Market Share Forecast by Country (2027-2032) Table 127. Europe Seasickness Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Seasickness Medicine Sales by Country (2021-2026) & (K Units) Table 129. Europe Seasickness Medicine Sales Market Share by Country (2021-2026) Table 130. Europe Seasickness Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Seasickness Medicine Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Seasickness Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Seasickness Medicine Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Seasickness Medicine Market Share by Country (2021-2026) Table 135. Europe Seasickness Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Seasickness Medicine Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Seasickness Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Seasickness Medicine Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Seasickness Medicine Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Seasickness Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Seasickness Medicine Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Seasickness Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Seasickness Medicine Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Seasickness Medicine Market Share by Country (2021-2026) Table 145. Asia-Pacific Seasickness Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Seasickness Medicine Market Share Forecast by Country (2027-2032) Table 147. Latin America Seasickness Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Seasickness Medicine Sales by Country (2021-2026) & (K Units) Table 149. Latin America Seasickness Medicine Sales Market Share by Country (2021-2026) Table 150. Latin America Seasickness Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Seasickness Medicine Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Seasickness Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Seasickness Medicine Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Seasickness Medicine Market Share by Country (2021-2026) Table 155. Latin America Seasickness Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Seasickness Medicine Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Seasickness Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Seasickness Medicine Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Seasickness Medicine Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Seasickness Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Seasickness Medicine Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Seasickness Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Seasickness Medicine Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Seasickness Medicine Market Share by Country (2021-2026) Table 165. Middle East and Africa Seasickness Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Seasickness Medicine Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Seasickness Medicine Distributors List Table 170. Seasickness Medicine Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Seasickness Medicine Image Figure 2. Global Seasickness Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Seasickness Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Seasickness Medicine Sales (2021-2032) & (K Units) Figure 5. Anticholinergic Image Figure 6. Global Anticholinergic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antihistamines Image Figure 8. Global Antihistamines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Seasickness Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Seasickness Medicine Market Share by Type 2025 VS 2032 Figure 13. North America Seasickness Medicine Sales Market Share in Volume by Type in 2025 Figure 14. North America Seasickness Medicine Sales Market Share in Value by Type in 2025 Figure 15. Europe Seasickness Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Seasickness Medicine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Seasickness Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Seasickness Medicine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Seasickness Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Seasickness Medicine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Seasickness Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Seasickness Medicine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Seasickness Medicine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Seasickness Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Seasickness Medicine Market Share by Application 2025 VS 2032 Figure 31. North America Seasickness Medicine Sales Market Share in Volume by Application in 2025 Figure 32. North America Seasickness Medicine Sales Market Share in Value by Application in 2025 Figure 33. Europe Seasickness Medicine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Seasickness Medicine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Seasickness Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Seasickness Medicine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Seasickness Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Seasickness Medicine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Seasickness Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Seasickness Medicine Sales Market Share in Value by Application in 2025 Figure 41. North America Seasickness Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Seasickness Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Seasickness Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Seasickness Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Seasickness Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Seasickness Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Seasickness Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Seasickness Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Seasickness Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Seasickness Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Seasickness Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Seasickness Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Seasickness Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Seasickness Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Seasickness Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Seasickness Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Seasickness Medicine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Seasickness Medicine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Anticholinergic
  • Antihistamines
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Baxter International
  • Caleb Pharmaceuticals
  • Myungmoon Pharm
  • Prestige Brands
  • WellSpring Pharmaceutical Corporation
  • GlaxoSmithKline
  • Pfizer
  • Mylan
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Seasickness Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Seasickness Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Seasickness Medicine Market by Type
  6. 1.3.1 Anticholinergic
  7. 1.3.2 Antihistamines
  8. 1.3.3 Others
  9. 1.4 Global Seasickness Medicine Market Size by Type
  10. 1.4.1 Global Seasickness Medicine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Seasickness Medicine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Seasickness Medicine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Seasickness Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Seasickness Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Seasickness Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Seasickness Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Seasickness Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Seasickness Medicine Industry Trends
  2. 2.2 Seasickness Medicine Industry Drivers
  3. 2.3 Seasickness Medicine Industry Opportunities and Challenges
  4. 2.4 Seasickness Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Seasickness Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Seasickness Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Seasickness Medicine Price (2021-2026)
  4. 3.4 Global Seasickness Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Seasickness Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Seasickness Medicine Company, Product Type & Application
  7. 3.7 Global Seasickness Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Seasickness Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Seasickness Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Seasickness Medicine Tier 1, Tier 2, and Tier 3
4 Seasickness Medicine Regional Status and Outlook
  1. 4.1 Global Seasickness Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Seasickness Medicine Historic Market Size by Region
  3. 4.2.1 Global Seasickness Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Seasickness Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Seasickness Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Seasickness Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Seasickness Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Seasickness Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Seasickness Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Seasickness Medicine by Application
  1. 5.1 Seasickness Medicine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Seasickness Medicine Market Size by Application
  5. 5.2.1 Global Seasickness Medicine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Seasickness Medicine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Seasickness Medicine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Seasickness Medicine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Seasickness Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Seasickness Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Seasickness Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Seasickness Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter International
  2. 6.1.1 Baxter International Company Information
  3. 6.1.2 Baxter International Business Overview
  4. 6.1.3 Baxter International Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter International Seasickness Medicine Product Portfolio
  6. 6.1.5 Baxter International Recent Developments
  7. 6.2 Caleb Pharmaceuticals
  8. 6.2.1 Caleb Pharmaceuticals Company Information
  9. 6.2.2 Caleb Pharmaceuticals Business Overview
  10. 6.2.3 Caleb Pharmaceuticals Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Caleb Pharmaceuticals Seasickness Medicine Product Portfolio
  12. 6.2.5 Caleb Pharmaceuticals Recent Developments
  13. 6.3 Myungmoon Pharm
  14. 6.3.1 Myungmoon Pharm Company Information
  15. 6.3.2 Myungmoon Pharm Business Overview
  16. 6.3.3 Myungmoon Pharm Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Myungmoon Pharm Seasickness Medicine Product Portfolio
  18. 6.3.5 Myungmoon Pharm Recent Developments
  19. 6.4 Prestige Brands
  20. 6.4.1 Prestige Brands Company Information
  21. 6.4.2 Prestige Brands Business Overview
  22. 6.4.3 Prestige Brands Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prestige Brands Seasickness Medicine Product Portfolio
  24. 6.4.5 Prestige Brands Recent Developments
  25. 6.5 WellSpring Pharmaceutical Corporation
  26. 6.5.1 WellSpring Pharmaceutical Corporation Company Information
  27. 6.5.2 WellSpring Pharmaceutical Corporation Business Overview
  28. 6.5.3 WellSpring Pharmaceutical Corporation Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 WellSpring Pharmaceutical Corporation Seasickness Medicine Product Portfolio
  30. 6.5.5 WellSpring Pharmaceutical Corporation Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Seasickness Medicine Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Seasickness Medicine Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Seasickness Medicine Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Seasickness Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Seasickness Medicine Product Portfolio
  54. 6.9.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Seasickness Medicine Sales by Country
  2. 7.1.1 North America Seasickness Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Seasickness Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Seasickness Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Seasickness Medicine Market Size by Country
  6. 7.2.1 North America Seasickness Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Seasickness Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Seasickness Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Seasickness Medicine Sales by Country
  2. 8.1.1 Europe Seasickness Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Seasickness Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Seasickness Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Seasickness Medicine Market Size by Country
  6. 8.2.1 Europe Seasickness Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Seasickness Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Seasickness Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Seasickness Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Seasickness Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Seasickness Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Seasickness Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Seasickness Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Seasickness Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Seasickness Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Seasickness Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Seasickness Medicine Sales by Country
  2. 10.1.1 South America Seasickness Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Seasickness Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Seasickness Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Seasickness Medicine Market Size by Country
  6. 10.2.1 South America Seasickness Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Seasickness Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Seasickness Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Seasickness Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Seasickness Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Seasickness Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Seasickness Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Seasickness Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Seasickness Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Seasickness Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Seasickness Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Seasickness Medicine Value Chain Analysis
  2. 12.1.1 Seasickness Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Seasickness Medicine Production Mode & Process
  7. 12.2 Seasickness Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Seasickness Medicine Distributors
  10. 12.2.3 Seasickness Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst